close

Global IT outage update - Monday 22 July

The issues affecting the supplier that provides our chemotherapy and immunotherapy treatments have now been resolved.

We want to thank our patients for being understanding and bearing with us and we apologise for any delays caused by this. Unless our teams contact you, please attend your appointment as planned. Throughout this incident, we have prioritised the most clinically urgent patients.

The Christie provides care and treatment for hundreds of people every day. The global IT outage last Friday (19 July 2024) affected many organisations but to put it into context, this affected less than a third of our patients.

Our staff have worked tirelessly over the weekend to deliver as many chemotherapy and immunotherapy treatments as possible and continue to do so to catch up on rescheduled treatments this week.

Skip to Content

Clinical outcomes

Monitoring clinical outcome data is an integral part of our quality assessment. It is led by Professor Andrew Renehan, supported by our Data Manager and the clinical team.

Collecting and monitoring

We prospectively collect our clinical data and outcomes across three linked databases for colorectal cancer, peritoneal tumours and metastases, and anal cancer.

This data is monitored regularly through our quarterly mortality and morbidity meeting. To record complications from our operations in a standardised way, we’ve used the National Cancer Institute (CCTAE) system since 2008. We’ve also included the Clavien-Dindo classification system since 2011. This allows us to compare and demonstrate that while our major surgical cases have increased each year, our complication rates are among the lowest in the world.

Colorectal and Peritoneal Oncology service report

We regularly produce service reports outlining our activity, events and outcomes. Read our annual service report 2022 and see what is happening in the Colorectal and Peritoneal Oncology service.

Last updated: March 2023